Catalyst Wire Dossier Catalyst Wire Dossier

Kiovig

human normal immunoglobulin (IVIg) · Takeda Manufacturing Austria AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kiovig, covering 2022-06-27 to 2022-06-27. Get the full timeline:

Most recent: EMA Authorised: Kiovig (human normal immunoglobulin (IVIg)) — Takeda Manufacturing Austria AG

See pricing